ロード中...
PKC EPSILON IS REQUIRED FOR KRAS-DRIVEN LUNG TUMORIGENESIS
Non-small cell lung cancer (NSCLC) is the most frequent subtype of lung cancer and remains a highly lethal malignancy and one of the leading causes of cancer deaths worldwide. Mutant KRAS is the prevailing oncogenic driver of lung adenocarcinoma, the most common histological form of NSCLC. In this s...
保存先:
| 出版年: | Cancer Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7962984/ https://ncbi.nlm.nih.gov/pubmed/32994205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-20-1300 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|